What is Sarepta Therapeutics, Inc.'s price / earnings?

Sarepta Therapeutics, Inc. (SRPT) reported price / earnings of 49.4× in Q4 2024.

What does price / earnings mean?

Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Sarepta Therapeutics, Inc. SRPT Price / earnings

Price / earnings at other companies

PfizerPFE

14.7×—

Regeneron PharmaceuticalsREGN

18.5×+3.1×

BioMarin PharmaceuticalsBMRN

20×-21.5×

PTC TherapeuticsPTCT

6.5×—

Catalyst PharmaceuticalCPRX

13.7×-1.3×

Krystal Biotech, Inc.KRYS

33.6×-8.3×

Other financials

Income statement

See full

Revenue$730.8M-1.9%

Operating income-$300.4M-961%

Net income$331.0M+174%

EPS (diluted)-$4.60-1,343%

Balance sheet

See full

Cash & equivalents$464.5M+92.8%

Total debt$198.5M-3.4%

Total equity$1.5B+31.7%

Total assets$3.2B-8.3%

Cash flow

See full

Operating cash flow-$202.7M+65.3%

CapEx$2.1M-95.2%

Free cash flow-$204.8M+67.3%

Valuation

See full

Market cap$1.82B-63.1%

Enterprise value$1.56B-67.2%

P/S0.8×—

Profitability

See full

Operating margin-50.8%-1.6pp

Net margin4.6%+2.4pp

FCF margin-28.7%-9.2pp

Returns & leverage

See full

Return on equity-23.6%-28.5pp

Debt / equity0.1×0.0×

Current ratio4.6×+0.6×

Where this comes from

Calculated from Sarepta Therapeutics, Inc.’s reported figures.

market cap/net income=49.4×

Based on the most recent quarter.

The official record: Sarepta Therapeutics, Inc.’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s price / earnings?: Sarepta Therapeutics, Inc. (SRPT) reported price / earnings of 49.4× in Q4 2024.
What does price / earnings mean?: Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.